Verywell Health on MSN16h
Coffee vs. Energy Drinks: Which Is Better for Your Caffeine Fix?
Wondering if coffee or energy drinks are better for you? Discover their pros, cons, and the healthiest way to get your ...
The Mail & Guardian18h
The Land Rover Defender: A living legend of Africa
The Land Rover Defender links a powerful legacy of exploration, resilience and family memories across generations ...
Ophthalmology Times20h
Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes
The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...
Pharmabiz21h
US FDA grants Fast Track designation to Johnson & Johnson’s nipocalimab to treat adult patients with moderate-to-severe Sjögren’s disease
Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...
Le Lézard19h
Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease
Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...
Games Magazine Brasil16h
SeuBet reinforces its identity as ‘The Bet of the Community’ and introduces new ambassadors
The sports betting market in Brazil is undergoing transformation, and brands that do not connect authentically with the ...
Paul Tan's Automotive News3h
2025 MG4 EV revealed in China – next-generation hatchback is larger and with toned down design
SAIC-owned MG Motor has taken to Weibo to reveal the next-generation MG4 EV, which it says will be the first global model for ...
Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward
Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...
The M&G share price soars 5% as it raises its dividend outlook despite £1.9bn in outflows
The M&G share price was given a boost this morning after its full-year results revealed a progressive dividend policy. Our ...